ACCC has developed a medical wallet card for patients on immunotherapy for cancer.
![[Publication] IO Wallet Card](https://cdn.sanity.io/images/0vv8moc6/accc-cancer/ca9802333e94fafacf62f040692cb807733a298e-300x250.png?fit=crop&auto=format)
Early recognition and prompt management of immune-related adverse events (irAEs) are integral to the effective delivery of immunotherapy for cancer. For patients, knowing who to call, when to call, and what immunotherapy they are receiving or have received is essential.
When a trip to an Emergency Department (ED) is required, clear communication and care coordination between ED clinicians and the treating oncologist are critical to expedite appropriate management of irAEs.
Equipping IO patients with a medical wallet card that states the individual is treated with immunotherapy for cancer, the warning signs of common irAEs, and 24/7 contact information for the treating oncology team eases the burden for patients and caregivers in an emergent situation.
To help, the ACCC Immuno-Oncology Institute has developed a medical wallet card for patients on immunotherapy for cancer. A downloadable print-ready PDF enables cancer programs & practices to have copies printed.
The IO wallet card is supported by a grant from Genentech.
Last updated July 2020.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
